TILT (TILT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
2024 marked a transformative year with a strategic shift to focus on Jupiter and divest Massachusetts retail assets, aiming for a more agile and capital-efficient organization.
Strategic review led to divestiture of Massachusetts retail stores and plans to exit remaining plant-touching assets in 2025, focusing on Jupiter vape hardware business.
Divestitures aim to unlock value, streamline operations, and improve access to mainstream financing and U.S. exchanges.
Leadership enhancements and organizational refinements implemented to drive innovation and growth in Jupiter.
Financial highlights
Q4 2024 revenue was $24.6M, down from $27M in Q3 and $37.5M year-over-year, mainly due to Jupiter's shift to a commission-based model.
Full-year 2024 revenue was $115.6M, down from $166M in 2023.
Q4 gross margin rose to 22% (from 14% in Q3 and 10% year-over-year); adjusted gross margin reached 24%.
Q4 net loss was $41.4M, up from $12.6M in Q3 and $22M year-over-year, driven by intangible asset impairments.
FY 2024 net loss increased to $99.7M from $62.4M, mainly due to higher non-cash impairment losses.
Adjusted EBITDA in Q4 improved to $0.5M from negative $1.6M in Q3 and prior year.
Year-end cash was $4.3M; notes payable increased to $72.1M from $52.2M a year earlier.
Outlook and guidance
Expectation to complete Massachusetts retail divestiture in Q2 2025 and remaining plant-touching asset sales by year-end.
Focused on expanding Jupiter’s product portfolio, including new supplier relationships and proprietary hardware.
Anticipated reduction in corporate overhead and headcount as part of business realignment.
Anticipate QMID device commercialization in Europe in Q2, pending final certification.
Strategic shift to non-plant touching business expected to improve refinancing and exchange listing opportunities.
Latest events from TILT
- Q2 revenue dropped 36% as Jupiter hardware declined, but Ohio adult-use launch offers growth.TILT
Q2 20241 Feb 2026 - Q3 revenue dropped 39% as focus shifted to inhalation tech and balance sheet improvement.TILT
Q3 202413 Jan 2026 - Revenue and net loss fell as asset-light, Jupiter-first strategy and divestitures advanced.TILT
Q1 202514 Nov 2025 - Revenue declined and net loss narrowed as focus shifted to Jupiter and asset-light operations.TILT
Q2 202519 Aug 2025